SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K was filed on August 6, 2012, reporting events occurring on August 1, 2012. The registrant, India Globalization Capital, Inc., is incorporated in Maryland. The filing addresses corporate governance changes specifically regarding the company's capital structure.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the amendment of the Articles of Incorporation.
Material Changes
Effective August 1, 2012, the Company amended its Amended and Restated Articles of Incorporation to increase its authorized common stock. This action was approved by the Board and stockholders at a special meeting on August 25, 2011.
- Authorized Common Stock: Increased from 75,000,000 shares to 150,000,000 shares.
- Authorized Preferred Stock: Remained unchanged at 1,000,000 shares.
- Total Authorized Shares: Increased from 76,000,000 to 151,000,000 shares.
- Aggregate Par Value: Increased from $7,600.00 to $15,100.00.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to disclose the legal amendment to the corporate charter.
Investor Verification Checklist
- Verify the effective date of the stock authorization increase (August 1, 2012).
- Confirm the new total authorized share count (151,000,000 shares).
- Review the attached Exhibit 3.1 for the full text of the Amended and Restated Articles of Incorporation.
- Note that this filing does not report any change in the number of shares currently issued or outstanding, only the authorized limit.